Relive vs ACASA Senior Care

ACASA Senior Care is the stronger opportunity and the choice is not close. The budget dimension alone makes it the obvious pick: at nearly $7 M AUV per unit, ACASA locations have the revenue to justify a full stack—POS, marketing automation, scheduling, back-office. Relive gives you no AUV, and its investment range caps at $401 K, implying unit-level revenue one or two orders of magnitude smaller. You sell high-ticket B2B software; ACASA’s franchisees can actually write the check.

Terrain and timing seal it. ACASA runs an approved-supplier procurement model, so you can compete on merit and get listed. Relive uses franchisor-controlled procurement, meaning your sales effort dies at a corporate gatekeeper you cannot bypass. On timing, ACASA’s FDD is current (2025, DUE), signaling active franchise sales and a live expansion pipeline you can ride. Relive’s FDD is overdue—regardless of its 300 % unit growth history, an OVERDUE filing freezes franchise sales and kills your near-term pipeline. Current unit TAM is a rounding error (7 vs. 6), but ACASA’s open, growing, and well-funded system makes TAM real; Relive’s hot growth number is a backward-looking stat attached to a closed, stalled brand.

The tradeoff is that Relive’s 300 % growth suggests explosive brand momentum that could rapidly multiply accounts—if it were still selling. But without an active FDD and with locked procurement, you cannot convert that growth into software seats. ACASA’s 40 % growth is healthy enough, and every new unit that opens is a well-funded, procurement-open prospect you can win immediately. That’s the smarter bet.

Verdict: ACASA Senior Care.